Chemotherapy (perioperative)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Chemotherapy (perioperative), covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 3]